Amyotrophic Lateral Sclerosis: From Molecular Basis to Therapies
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 31 August 2025 | Viewed by 68
Special Issue Editor
Interests: neurodegenerative disorders; genetics; epigenetics; biomarker discovery; genome instability
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Amyotrophic Lateral Sclerosis (ALS) is one of the most common neurodegenerative diseases, characterized by progressive paralysis and death, usually due to respiratory failure. Despite significant advancements in understanding ALS pathomechanisms over the past decades, its exact cause remains unknown, and no effective treatment is currently available. As a result, ALS continues to be a major focus of scientific research.
This Special Issue aims to collect both original research and review articles exploring innovative pathomechanisms and potential therapeutic targets, such as:
(1) Novel candidate genes and gene-specific therapeutic approaches
(2) Epigenetic mechanisms in ALS pathogenesis
(3) Innovative disease models for ALS research
(4) Neuroinflammatory and immune system contributions to ALS progression
(5) Mitochondrial dysfunction and oxidative stress as key pathogenic factors
We welcome contributions that offer new insights into these topics, helping to advance our understanding of ALS and uncover potential therapeutic strategies.
Dr. Matteo Bordoni
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ALS
- pathomechanisms
- genetics
- epigenetics
- disease models
- neuroinflammation
- mithocondria
- oxidative stress
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
